It doesn't require excessively low temperatures to keep in storage and reached an overall efficacy rate of 66% in the 44,000 person study of patients with moderate to severe forms of COVID-19.
The trial also indicated an 85% rate of protection against patients with more severe forms and a 57% rate of efficacy against the new strain of the virus recently identified in South Africa.
Curious about what Jim Cramer and his team at Action Alerts PLUS are watching in the markets? Watch Cramer's exclusive members-only Daily Rundown show on Action Alerts PLUS following TheStreet Live.
Recap TheStreet Live: Everything Moving the Markets Friday
Latest Videos From TheStreet and Jim Cramer: